Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial dysfunction and the metabolic syndrome.

Gary E McVeigh1, Jay N Cohn

  • 1Cardiovascular Division, Mayo Mail Code 508, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN 55455, USA.

Current Diabetes Reports
|March 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure.

ESC heart failure·2022
Same author

Early cardiovascular structural and functional abnormalities as a guide to future morbid events.

European journal of preventive cardiology·2021
Same author

NT-proBNP for Risk Prediction in Heart Failure: Identification of Optimal Cutoffs Across Body Mass Index Categories.

JACC. Heart failure·2021
Same author

Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data.

Clinical research in cardiology : official journal of the German Cardiac Society·2021
Same author

Biostatistics Versus Pathophysiology.

Circulation·2021
Same author

Low-dose colchicine reduced risk for cardiovascular events in chronic coronary disease.

Annals of internal medicine·2021
Same journal

Continuous Glucose Monitoring in Type 2 Diabetes: Clinical Outcomes, Disparities in Access, and Cost-effectiveness.

Current diabetes reports·2026
Same journal

Beyond Inflammation - A Multidisciplinary Approach to Managing Obesity and Cardiometabolic Risk in Inflammatory Bowel Disease.

Current diabetes reports·2026
Same journal

Climate Change and Diabetes Outcomes: Evidence from Climate-Vulnerable Regions.

Current diabetes reports·2026
Same journal

Efficacy and safety of once-weekly basal insulin analogs versus daily basal insulin analogs in adults with type 2 diabetes: a systematic review and meta-analysis.

Current diabetes reports·2026
Same journal

Use of Glucagon-Like Peptide-1 Receptor Agonists in Women with Type 2 Diabetes Before Pregnancy: Addressing the Dilemma in A Real-World Setting.

Current diabetes reports·2026
Same journal

Can Behavioral Interventions Promote Health Equity in Pediatric Type 1 Diabetes? A Narrative Review of Promising Treatments.

Current diabetes reports·2026
See all related articles

Metabolic syndrome, characterized by obesity and insulin resistance, accelerates inflammation and cardiovascular risk. Early detection of impaired vascular function is key for managing metabolic syndrome and preventing type 2 diabetes.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Vascular Biology

Background:

  • Metabolic syndrome is a prevalent condition resulting from genetic, hormonal, and lifestyle interactions.
  • Obesity and insulin resistance are central components, contributing to inflammation, coagulation, and increased cardiovascular risk.
  • Impaired endothelial function marks the early stages of atherosclerosis in metabolic syndrome.

Purpose of the Study:

  • To highlight the role of inflammation and coagulation in metabolic syndrome.
  • To emphasize the early detection of impaired endothelial function in atherogenesis.
  • To explore the potential of monitoring subclinical vascular disease for risk stratification and therapeutic guidance.

Main Methods:

  • Review of existing literature on metabolic syndrome, inflammation, and cardiovascular risk.

Related Experiment Videos

  • Analysis of the relationship between metabolic syndrome components and atherosclerosis development.
  • Discussion of noninvasive vascular health assessment techniques.

    • Main Results:

    • Metabolic syndrome accelerates inflammation and coagulation, increasing cardiovascular risk.
    • Impaired endothelial function is an early indicator of atherosclerosis in metabolic syndrome.
    • Subclinical vascular disease detection can refine cardiovascular risk stratification.

    Conclusions:

    • Metabolic syndrome components, including inflammation and insulin resistance, significantly elevate cardiovascular risk.
    • Early identification of endothelial dysfunction is crucial for managing metabolic syndrome and preventing type 2 diabetes.
    • Noninvasive vascular assessments can guide interventions for improved vascular protection in metabolic syndrome patients.